Wave-Front Optimized vs Topography-Guided Ablation for Refractive Surgery
Trial Summary
What is the purpose of this trial?
This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ablation profile provides the best visual outcome.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Topography-guided (TG) ablation and Wave-Front Optimized (WFO) ablation for refractive surgery?
Research comparing topography-guided and wavefront-optimized LASIK for myopia shows both treatments are effective, with some studies indicating differences in visual outcomes and aberrations (imperfections in the eye's optical system). These findings suggest that both methods can successfully correct vision, but may offer slightly different benefits depending on individual eye characteristics.12345
Is Wave-Front Optimized and Topography-Guided Ablation safe for refractive surgery?
Research comparing Wave-Front Optimized and Topography-Guided Ablation for LASIK surgery in treating myopia and astigmatism generally focuses on visual outcomes and safety. These studies suggest that both methods are safe for correcting vision issues like myopia, with no significant safety concerns reported.12456
How does topography-guided ablation differ from wavefront-optimized ablation in refractive surgery?
Topography-guided ablation customizes the laser treatment based on the unique shape of the cornea, potentially offering more precise correction for vision issues, while wavefront-optimized ablation focuses on reducing visual distortions by considering the eye's overall wavefront (light path) characteristics.12347
Research Team
CHARISMA B EVANGELISTA, MD
Principal Investigator
59th Medical Wing
Eligibility Criteria
This trial is for people aged 21-50 who are eligible for PRK or LASIK eye surgery, have had stable vision with less than a half diopter change, and can attend follow-ups. They must live within 60 miles of the clinic and stay in the area for at least six months post-surgery. Those with certain eye conditions, previous surgeries, or women who are pregnant/breastfeeding cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Evaluation
Standard preoperative evaluation including vision assessments, contrast sensitivity, and keratometry
Surgery
Patients undergo LASIK or PRK surgery with either Wave-Front Optimized or Topography-guided ablation
Post-operative Care
Standard post-operative care with evaluations at day 1, week 1, month 1, month 3, and month 6
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Topography-guided (TG) ablation
- Wave-Front Optimized (WFO) ablation
Find a Clinic Near You
Who Is Running the Clinical Trial?
59th Medical Wing
Lead Sponsor